We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Technology for Making Nanoparticles

By Biotechdaily staff writers
Posted on 11 Jul 2005
A new technology breakthrough can create the world's tiniest manufactured particles for delivering drugs and biologic materials into the human body.

The technology provides control over shape, size, and composition of material when manufacturing nanoparticles. More...
This innovative new process has widespread applications, including drug formulation, drug delivery, medical imaging and disease detection, and nonmedical applications such as sensors, ink-jet printing, and microelectronics.

Called PRINT (particle replication in nonwetting templates), the technology enables the fabrication of custom-sized, monodispersed, and shape-specific particles of virtually any material and encapsulating nearly any active cargo. The latter includes delicate substances, biologic agents, and small molecules, which can be delivered through a full range of injectable, pulmonary, topical, and oral methods.

"This technique allows for development of a particle foundry, similar to continuous manufacturing techniques in the microelectronics industry, but for fabricating delicate particles for use in nanomedicines and other emerging technologies,” said Dr. W. Lowry Caudill, executive chairman of Liquidia Technologies (Research Triangle Park, NC, USA).

"Nanoparticle fabrication, until now, has focused on inorganic materials such as metals that involve harsh manufacturing methods and often are not useful for medical applications,” explained Joseph M. DeSimone, co-founder of Liquidia Technologies and professor of chemistry and chemical engineering at the University of North Carolina at Chapel Hill (USA). "This technology allows for the first time fabrication of particles for vaccines and therapies that are nontoxic for patients since the particles themselves are made from well-known bioabsorbable organic materials. Impressions are made with what we call liquid Teflon, and the resulting molds look something like ice cube trays with tiny cavities in them. After that, we mold the carrier and fragile functional materials into whatever particles we want.”






Related Links:
Liquidia Technologies

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LIAISON Murex Anti-HDV Immunoassay is the first fully automated FDA-authorized immunoassay for HDV detection in the U.S. (Photo courtesy of Diasorin)

Fully Automated Immunoassay Test Detects HDV Co‑Infection and Super-Infection

Hepatitis delta, also known as hepatitis D, is caused by the hepatitis delta virus (HDV). It is a viral liver infection that can result in one of the most severe forms of viral hepatitis.... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.